The antitumor effects of geraniol: Modulation of cancer hallmark pathways (Review)
- Authors:
- Minsoo Cho
- Insuk So
- Jung Nyeo Chun
- Ju-Hong Jeon
-
Affiliations: Undergraduate Research Program, Seoul National University College of Medicine, Seoul 03080, Republic of Korea, Department of Physiology and Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea - Published online on: March 9, 2016 https://doi.org/10.3892/ijo.2016.3427
- Pages: 1772-1782
-
Copyright: © Cho et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Mahmoud SS and Croteau RB: Strategies for transgenic manipulation of monoterpene biosynthesis in plants. Trends Plant Sci. 7:366–373. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Guimarães AG, Quintans JS and Quintans LJ Jr: Monoterpenes with analgesic activity: a systematic review. Phytother Res. 27:1–15. 2013. View Article : Google Scholar | |
|
de Cássia da Silveira e Sá R, Andrade LN and de Sousa DP: A review on anti-inflammatory activity of monoterpenes. Molecules. 18:1227–1254. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Bhalla Y, Gupta VK and Jaitak V: Anticancer activity of essential oils: A review. J Sci Food Agric. 93:3643–3653. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Barreto RS, Albuquerque-Júnior RL, Araújo AA, Almeida JR, Santos MR, Barreto AS, DeSantana JM, Siqueira-Lima PS, Quintans JS and Quintans-Júnior LJ: A systematic review of the wound-healing effects of monoterpenes and iridoid derivatives. Molecules. 19:846–862. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hasan SK and Sultana S: Geraniol attenuates 2-acetylamino-fluorene induced oxidative stress, inflammation and apoptosis in the liver of wistar rats. Toxicol Mech Methods. 25:559–573. 2015. | |
|
Medicherla K, Sahu BD, Kuncha M, Kumar JM, Sudhakar G and Sistla R: Oral administration of geraniol ameliorates acute experimental murine colitis by inhibiting pro-inflammatory cytokines and NF-κB signaling. Food Funct. 6:2984–2995. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Soubh AA, Abdallah DM and El-Abhar HS: Geraniol ameliorates TNBS-induced colitis: Involvement of Wnt/β-catenin, p38MAPK, NF-κB, and PPARγ signaling pathways. Life Sci. 136:142–150. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kozioł A, Stryjewska A, Librowski T, Sałat K, Gaweł M, Moniczewski A and Lochyński S: An overview of the pharmacological properties and potential applications of natural monoterpenes. Mini Rev Med Chem. 14:1156–1168. 2014. View Article : Google Scholar | |
|
Gould MN: Cancer chemoprevention and therapy by monoterpenes. Environ Health Perspect. 105(Suppl 4): 977–979. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Crowell PL: Prevention and therapy of cancer by dietary monoterpenes. J Nutr. 129:775S–778S. 1999.PubMed/NCBI | |
|
Chen TC, Fonseca CO and Schönthal AH: Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy. Am J Cancer Res. 5:1580–1593. 2015.PubMed/NCBI | |
|
Samaila D, Toy BJ, Wang RC and Elegbede JA: Monoterpenes enhanced the sensitivity of head and neck cancer cells to radiation treatment in vitro. Anticancer Res. 24:3089–3095. 2004.PubMed/NCBI | |
|
Bardon S, Foussard V, Fournel S and Loubat A: Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression. Cancer Lett. 181:187–194. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Sobral MV, Xavier AL, Lima TC and de Sousa DP: Antitumor activity of monoterpenes found in essential oils. Sci World J. 2014:9534512014. View Article : Google Scholar | |
|
Lapczynski A, Bhatia SP, Foxenberg RJ, Letizia CS and Api AM: Fragrance material review on geraniol. Food Chem Toxicol. 46(Suppl 11): S160–S170. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Solórzano-Santos F and Miranda-Novales MG: Essential oils from aromatic herbs as antimicrobial agents. Curr Opin Biotechnol. 23:136–141. 2012. View Article : Google Scholar | |
|
Tiwari M and Kakkar P: Plant derived antioxidants - Geraniol and camphene protect rat alveolar macrophages against t-BHP induced oxidative stress. Toxicol In Vitro. 23:295–301. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
de Carvalho KI, Bonamin F, Dos Santos RC, Périco LL, Beserra FP, de Sousa DP, Filho JM, da Rocha LR and Hiruma-Lima CA: Geraniol - a flavoring agent with multifunctional effects in protecting the gastric and duodenal mucosa. Naunyn Schmiedebergs Arch Pharmacol. 387:355–365. 2014. View Article : Google Scholar | |
|
Rekha KR, Selvakumar GP, Sethupathy S, Santha K and Sivakamasundari RI: Geraniol ameliorates the motor behavior and neurotrophic factors inadequacy in MPTP-induced mice model of Parkinson's disease. J Mol Neurosci. 51:851–862. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Burke YD, Stark MJ, Roach SL, Sen SE and Crowell PL: Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol. Lipids. 32:151–156. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Carnesecchi S, Schneider Y, Ceraline J, Duranton B, Gosse F, Seiler N and Raul F: Geraniol, a component of plant essential oils, inhibits growth and polyamine biosynthesis in human colon cancer cells. J Pharmacol Exp Ther. 298:197–200. 2001.PubMed/NCBI | |
|
Duncan RE, Lau D, El-Sohemy A and Archer MC: Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity. Biochem Pharmacol. 68:1739–1747. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Ong TP, Heidor R, de Conti A, Dagli ML and Moreno FS: Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase. Carcinogenesis. 27:1194–1203. 2006. View Article : Google Scholar | |
|
Kim SH, Bae HC, Park EJ, Lee CR, Kim BJ, Lee S, Park HH, Kim SJ, So I, Kim TW, et al: Geraniol inhibits prostate cancer growth by targeting cell cycle and apoptosis pathways. Biochem Biophys Res Commun. 407:129–134. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Galle M, Crespo R, Kladniew BR, Villegas SM, Polo M and de Bravo MG: Suppression by geraniol of the growth of A549 human lung adenocarcinoma cells and inhibition of the mevalonate pathway in culture and in vivo: Potential use in cancer chemotherapy. Nutr Cancer. 66:888–895. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Carnesecchi S, Langley K, Exinger F, Gosse F and Raul F: Geraniol, a component of plant essential oils, sensitizes human colonic cancer cells to 5-Fluorouracil treatment. J Pharmacol Exp Ther. 301:625–630. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Carnesecchi S, Bras-Gonçalves R, Bradaia A, Zeisel M, Gossé F, Poupon MF and Raul F: Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts. Cancer Lett. 215:53–59. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Polo MP and de Bravo MG: Effect of geraniol on fatty-acid and mevalonate metabolism in the human hepatoma cell line Hep G2. Biochem Cell Biol. 84:102–111. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kim SH, Park EJ, Lee CR, Chun JN, Cho NH, Kim IG, Lee S, Kim TW, Park HH, So I, et al: Geraniol induces cooperative interaction of apoptosis and autophagy to elicit cell death in PC-3 prostate cancer cells. Int J Oncol. 40:1683–1690. 2012. | |
|
Crespo R, Montero Villegas S, Abba MC, de Bravo MG and Polo MP: Transcriptional and posttranscriptional inhibition of HMGCR and PC biosynthesis by geraniol in 2 Hep-G2 cell proliferation linked pathways. Biochem Cell Biol. 91:131–139. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zimmermann GR, Lehár J and Keith CT: Multi-target therapeutics: When the whole is greater than the sum of the parts. Drug Discov Today. 12:34–42. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Efferth T and Koch E: Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr Drug Targets. 12:122–132. 2011. View Article : Google Scholar | |
|
Rather MA, Bhat BA and Qurishi MA: Multicomponent phyto-therapeutic approach gaining momentum: Is the ‘one drug to fit all’ model breaking down? Phytomedicine. 21:1–14. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Tao L, Zhu F, Xu F, Chen Z, Jiang YY and Chen YZ: Co-targeting cancer drug escape pathways confers clinical advantage for multi-target anticancer drugs. Pharmacol Res. 102:123–131. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Huang S and Kauffman S: How to escape the cancer attractor: Rationale and limitations of multi-target drugs. Semin Cancer Biol. 23:270–278. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Hanahan D and Weinberg RA: The hallmarks of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Floor SL, Dumont JE, Maenhaut C and Raspe E: Hallmarks of cancer: Of all cancer cells, all the time? Trends Mol Med. 18:509–515. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Ellenbroek SI and van Rheenen J: Imaging hallmarks of cancer in living mice. Nat Rev Cancer. 14:406–418. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Horne SD, Pollick SA and Heng HH: Evolutionary mechanism unifies the hallmarks of cancer. Int J Cancer. 136:2012–2021. 2015. View Article : Google Scholar | |
|
Sonnenschein C and Soto AM: The aging of the 2000 and 2011 Hallmarks of Cancer reviews: A critique. J Biosci. 38:651–663. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Carnesecchi S, Bradaia A, Fischer B, Coelho D, Schöller-Guinard M, Gosse F and Raul F: Perturbation by geraniol of cell membrane permeability and signal transduction pathways in human colon cancer cells. J Pharmacol Exp Ther. 303:711–715. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Hoshi D, Nakajima A, Inoue E, Shidara K, Sato E, Kitahama M, Seto Y, Tanaka E, Urano W, Ichikawa N, et al: Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab. Mod Rheumatol. 22:122–127. 2012. View Article : Google Scholar | |
|
Chaudhary SC, Siddiqui MS, Athar M and Alam MS: Geraniol inhibits murine skin tumorigenesis by modulating COX-2 expression, Ras-ERK1/2 signaling pathway and apoptosis. J Appl Toxicol. 33:828–837. 2013. View Article : Google Scholar | |
|
Vinothkumar V, Manoharan S, Sindhu G, Nirmal MR and Vetrichelvi V: Geraniol modulates cell proliferation, apoptosis, inflammation, and angiogenesis during 7,12-dimethylbenz[a] anthracene-induced hamster buccal pouch carcinogenesis. Mol Cell Biochem. 369:17–25. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Cardozo MT, de Conti A, Ong TP, Scolastici C, Purgatto E, Horst MA, Bassoli BK and Moreno FS: Chemopreventive effects of β-ionone and geraniol during rat hepatocarcinogenesis promotion: Distinct actions on cell proliferation, apoptosis, HMGCoA reductase, and RhoA. J Nutr Biochem. 22:130–135. 2011. View Article : Google Scholar | |
|
Wiseman DA, Werner SR and Crowell PL: Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21Cip1 and p27Kip1 in human pancreatic adenocarcinoma cells. J Pharmacol Exp Ther. 320:1163–1170. 2007. View Article : Google Scholar | |
|
Vieira A, Heidor R, Cardozo MT, Scolastici C, Purgatto E, Shiga TM, Barbisan LF, Ong TP and Moreno FS: Efficacy of geraniol but not of β-ionone or their combination for the chemoprevention of rat colon carcinogenesis. Braz J Med Biol Res. 44:538–545. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ahmad ST, Arjumand W, Seth A, Nafees S, Rashid S, Ali N and Sultana S: Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways. Toxicology. 290:69–81. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Vinothkumar V and Manoharan S: Chemopreventive efficacy of geraniol against 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Redox Rep. 16:91–100. 2011. View Article : Google Scholar | |
|
Khan AQ, Khan R, Qamar W, Lateef A, Rehman MU, Tahir M, Ali F, Hamiza OO, Hasan SK and Sultana S: Geraniol attenuates 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced oxidative stress and inflammation in mouse skin: Possible role of p38 MAP Kinase and NF-κB. Exp Mol Pathol. 94:419–429. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Madankumar A, Jayakumar S, Gokuladhas K, Rajan B, Raghunandhakumar S, Asokkumar S and Devaki T: Geraniol modulates tongue and hepatic phase I and phase II conjugation activities and may contribute directly to the chemopreventive activity against experimental oral carcinogenesis. Eur J Pharmacol. 705:148–155. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wittig C, Scheuer C, Parakenings J, Menger MD and Laschke MW: Geraniol suppresses angiogenesis by down-regulating vascular endothelial growth factor (VEGF)/VEGFR-2 signaling. PLoS One. 10:e01319462015. View Article : Google Scholar | |
|
Gysin S, Salt M, Young A and McCormick F: Therapeutic strategies for targeting ras proteins. Genes Cancer. 2:359–372. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wallace HM: Targeting polyamine metabolism: A viable therapeutic/preventative solution for cancer? Expert Opin Pharmacother. 8:2109–2116. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Peters GJ, Backus HH, Freemantle S, van Triest B, Codacci-Pisanelli G, van der Wilt CL, Smid K, Lunec J, Calvert AH, Marsh S, et al: Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta. 1587:194–205. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Popat S, Matakidou A and Houlston RS: Thymidylate synthase expression and prognosis in colorectal cancer: A systematic review and meta-analysis. J Clin Oncol. 22:529–536. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Topolcan O and Holubec L Jr: The role of thymidine kinase in cancer diseases. Expert Opin Med Diagn. 2:129–141. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Jin X, Sun J, Miao X, Liu G and Zhong D: Inhibitory effect of geraniol in combination with gemcitabine on proliferation of BXPC-3 human pancreatic cancer cells. J Int Med Res. 41:993–1001. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Polo MP, Crespo R and de Bravo MG: Geraniol and simvastatin show a synergistic effect on a human hepatocarcinoma cell line. Cell Biochem Funct. 29:452–458. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Yu SG, Hildebrandt LA and Elson CE: Geraniol, an inhibitor of mevalonate biosynthesis, suppresses the growth of hepatomas and melanomas transplanted to rats and mice. J Nutr. 125:2763–2767. 1995.PubMed/NCBI | |
|
Shoff SM, Grummer M, Yatvin MB and Elson CE: Concentration-dependent increase of murine P388 and B16 population doubling time by the acyclic monoterpene geraniol. Cancer Res. 51:37–42. 1991.PubMed/NCBI | |
|
He L, Mo H, Hadisusilo S, Qureshi AA and Elson CE: Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J Nutr. 127:668–674. 1997.PubMed/NCBI | |
|
Mo H, Tatman D, Jung M and Elson CE: Farnesyl anthranilate suppresses the growth, in vitro and in vivo, of murine B16 melanomas. Cancer Lett. 157:145–153. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
McAnally JA, Jung M and Mo H: Farnesyl-O-acetylhydroquinone and geranyl-O-acetylhydroquinone suppress the proliferation of murine B16 melanoma cells, human prostate and colon adenocarcinoma cells, human lung carcinoma cells, and human leukemia cells. Cancer Lett. 202:181–192. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Aqil F, Munagala R, Jeyabalan J and Vadhanam MV: Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett. 334:133–141. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Chung AS and Ferrara N: Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol. 27:563–584. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
DeBose-Boyd RA: Feedback regulation of cholesterol synthesis: Sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res. 18:609–621. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Chun JN, Lim JM, Kang Y, Kim EH, Shin YC, Kim HG, Jang D, Kwon D, Shin SY, So I, et al: A network perspective on unraveling the role of TRP channels in biology and disease. Pflugers Arch. 466:173–182. 2014. View Article : Google Scholar | |
|
Barabási AL, Gulbahce N and Loscalzo J: Network medicine: A network-based approach to human disease. Nat Rev Genet. 12:56–68. 2011. View Article : Google Scholar : | |
|
Furlong LI: Human diseases through the lens of network biology. Trends Genet. 29:150–159. 2013. View Article : Google Scholar | |
|
Ideker T and Krogan NJ: Differential network biology. Mol Syst Biol. 8:5652012. View Article : Google Scholar : PubMed/NCBI | |
|
Grossglauser M and Saner H: Data-driven healthcare: From patterns to actions. Eur J Prev Cardiol. 21(Suppl): 14–17. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lusher SJ, McGuire R, van Schaik RC, Nicholson CD and de Vlieg J: Data-driven medicinal chemistry in the era of big data. Drug Discov Today. 19:859–868. 2014. View Article : Google Scholar | |
|
Quan Y, Wang ZY, Xiong M, Xiao ZT and Zhang HY: Dissecting traditional Chinese medicines by omics and bioinformatics. Nat Prod Commun. 9:1391–1396. 2014. | |
|
Quinn BJ, Kitagawa H, Memmott RM, Gills JJ and Dennis PA: Repositioning metformin for cancer prevention and treatment. Trends Endocrinol Metab. 24:469–480. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Anisimov VN: Do metformin a real anticarcinogen? A critical reappraisal of experimental data. Ann Transl Med. 2:602014.PubMed/NCBI |
